//--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~subject:"Tenofovir"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: subject:"Entecavir"
Narrow search
Delete all filters
| 1 applied filter
Year of publication
From:
To:
Subject
All
Tenofovir
Adefovir
3
Cost-utility
3
Entecavir
3
Hepatitis-B
3
Lamivudine
3
Research-and-development
2
Antiretrovirals
1
Peginterferon-alfa-2a
1
Telbivudine
1
more ...
less ...
Online availability
All
Undetermined
1
Type of publication
All
Article
1
Language
All
Undetermined
1
Author
All
Bentley, Anthony
1
Dakin, Helen
1
Fidler, Carrie
1
Fung, Scott
1
Sherman, Morris
1
Published in...
All
PharmacoEconomics
1
Source
All
RePEc
1
Showing
1
-
1
of
1
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Cost Effectiveness of Tenofovir Disoproxil Fumarate for the Treatment of Chronic Hepatitis B from a Canadian Public Payer Perspective
Dakin, Helen
;
Sherman, Morris
;
Fung, Scott
;
Fidler, Carrie
- In:
PharmacoEconomics
29
(
2011
)
12
,
pp. 1075-1091
compared with lamivudine then tenofovir. First-line tenofovir DF strongly dominated first-line
entecavir
. Giving tenofovir DF …
Persistent link: https://www.econbiz.de/10010614343
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->